11C-Metomidate PET/CT for Endocrine Hypertension and Characterisation of Adrenal Tumours

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 30, 2019

Primary Completion Date

December 31, 2024

Study Completion Date

July 31, 2025

Conditions
Primary Aldosteronism Due to Aldosterone Producing AdenomaPrimary AldosteronismAdrenal Tumors
Interventions
COMBINATION_PRODUCT

11C-Metomidate PET/CT imaging at Clinical Imaging Research Centre

11C-Metomidate PET/CT imaging at Clinical Imaging Research Centre

Trial Locations (7)

Unknown

RECRUITING

Changi General Hospital, Singapore

RECRUITING

Khoo Teck Puat Hospital, Singapore

RECRUITING

National University Hospital, Singapore

RECRUITING

Ng Teng Fong General Hospital, Singapore

RECRUITING

Sengkang General Hospital, Singapore

RECRUITING

Singapore General Hospital, Singapore

RECRUITING

Tan Tock Seng Hospital, Singapore

Sponsors
All Listed Sponsors
collaborator

National University Health System, Singapore

OTHER

collaborator

Clinical Imaging Research Centre

UNKNOWN

collaborator

Singapore General Hospital

OTHER

collaborator

Tan Tock Seng Hospital

OTHER

collaborator

Khoo Teck Puat Hospital

OTHER

collaborator

Ng Teng Fong General Hospital

OTHER

collaborator

Sengkang General Hospital

OTHER

lead

Changi General Hospital

OTHER